{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:49:45Z","timestamp":1790808585154,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H05591"],"award-info":[{"award-number":["20H05591"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H06389"],"award-info":[{"award-number":["17H06389"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJER1902"],"award-info":[{"award-number":["JPMJER1902"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Drug-resistant tuberculosis (TB) is a growing public health problem. There is an urgent need for information regarding cross-resistance and collateral sensitivity relationships among drugs and the genetic determinants of anti-TB drug resistance for developing strategies to suppress the emergence of drug-resistant pathogens. To identify mutations that confer resistance to anti-TB drugs in <jats:italic>Mycobacterium<\/jats:italic> species, we performed the laboratory evolution of nonpathogenic <jats:italic>Mycobacterium smegmatis<\/jats:italic>, which is closely related to <jats:italic>Mycobacterium tuberculosis<\/jats:italic>, against ten anti-TB drugs. Next, we performed whole-genome sequencing and quantified the resistance profiles of each drug-resistant strain against 24 drugs. We identified the genes with novel meropenem (MP) and linezolid (LZD) resistance-conferring mutation, which also have orthologs, in <jats:italic>M. tuberculosis<\/jats:italic> H37Rv. Among the 240 possible drug combinations, we identified 24 pairs that confer cross-resistance and 18 pairs that confer collateral sensitivity. The acquisition of bedaquiline or linezolid resistance resulted in collateral sensitivity to several drugs, while the acquisition of MP resistance led to multidrug resistance. The MP-evolved strains showed cross-resistance to rifampicin and clarithromycin owing to the acquisition of a mutation in the intergenic region of the Rv2864c ortholog, which encodes a penicillin-binding protein, at an early stage. These results provide a new insight to tackle drug-resistant TB.<\/jats:p>","DOI":"10.1038\/s41598-021-94645-z","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T10:03:49Z","timestamp":1627034629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Laboratory evolution of Mycobacterium on agar plates for analysis of resistance acquisition and drug sensitivity profiles"],"prefix":"10.1038","volume":"11","author":[{"given":"Tomoya","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsue","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazuki","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Furusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"94645_CR1","unstructured":"World Health Organization. Global tuberculosis report. (2019). https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/329368\/9789241565714-eng.pdf."},{"key":"94645_CR2","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1093\/cid\/ciu547","volume":"59","author":"KA Bauer","year":"2014","unstructured":"Bauer, K. A., Perez, K. K., Forrest, G. N. & Goff, D. A. Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin. Infect. Dis. 59, S134\u2013S145 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"94645_CR3","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/ng.2735","volume":"45","author":"H Zhang","year":"2013","unstructured":"Zhang, H. et al. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat. Genet. 45, 1255\u20131260 (2013).","journal-title":"Nat. Genet."},{"key":"94645_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1001880","volume":"12","author":"KA Cohen","year":"2015","unstructured":"Cohen, K. A. et al. Evolution of extensively drug-resistant tuberculosis over four decades: Whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal. PLoS Med. 12, 1\u201322 (2015).","journal-title":"PLoS Med."},{"key":"94645_CR5","doi-asserted-by":"publisher","first-page":"7119","DOI":"10.1038\/ncomms8119","volume":"6","author":"V Eldholm","year":"2015","unstructured":"Eldholm, V. et al. Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain. Nat. Commun. 6, 7119 (2015).","journal-title":"Nat. Commun."},{"key":"94645_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/ng.3767","volume":"49","author":"AL Manson","year":"2017","unstructured":"Manson, A. L. et al. Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance. Nat. Genet. 49, 395\u2013402 (2017).","journal-title":"Nat. Genet."},{"key":"94645_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(19)31882-3","volume":"394","author":"C Lange","year":"2019","unstructured":"Lange, C. et al. Management of drug-resistant tuberculosis. Lancet 394, 953\u2013966 (2019).","journal-title":"Lancet"},{"key":"94645_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/ng.3548","volume":"48","author":"CA Desjardins","year":"2016","unstructured":"Desjardins, C. A. et al. Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in d-cycloserine resistance. Nat. Genet. 48, 544\u2013551 (2016).","journal-title":"Nat. Genet."},{"key":"94645_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1126\/scitranslmed.3006609","volume":"5","author":"L Imamovic","year":"2013","unstructured":"Imamovic, L. & Sommer, M. O. A. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci. Transl. Med. 5, 20 (2013).","journal-title":"Sci. Transl. Med."},{"key":"94645_CR10","doi-asserted-by":"publisher","first-page":"14494","DOI":"10.1073\/pnas.1409800111","volume":"111","author":"S Kim","year":"2014","unstructured":"Kim, S., Lieberman, T. D. & Kishony, R. Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance. Proc. Natl. Acad. Sci. USA 111, 14494\u201314499 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"94645_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pcbi.1004493","volume":"11","author":"D Nichol","year":"2015","unstructured":"Nichol, D. et al. Steering evolution with sequential therapy to prevent the emergence of bacterial antibiotic resistance. PLoS Comput. Biol. 11, 1\u201319 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"94645_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pbio.1002104","volume":"13","author":"A Fuentes-Hernandez","year":"2015","unstructured":"Fuentes-Hernandez, A. et al. Using a sequential regimen to eliminate bacteria at sublethal antibiotic dosages. PLoS Biol. 13, 1\u201317 (2015).","journal-title":"PLoS Biol."},{"key":"94645_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tim.2015.02.009","volume":"23","author":"C P\u00e1l","year":"2015","unstructured":"P\u00e1l, C., Papp, B. & L\u00e1z\u00e1r, V. Collateral sensitivity of antibiotic-resistant microbes. Trends Microbiol. 23, 401\u2013407 (2015).","journal-title":"Trends Microbiol."},{"key":"94645_CR14","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1038\/ncomms5352","volume":"5","author":"V L\u00e1z\u00e1r","year":"2014","unstructured":"L\u00e1z\u00e1r, V. et al. Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network. Nat. Commun. 5, 4352 (2014).","journal-title":"Nat. Commun."},{"key":"94645_CR15","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1038\/s41467-020-19713-w","volume":"11","author":"T Maeda","year":"2020","unstructured":"Maeda, T. et al. High-throughput laboratory evolution reveals evolutionary constraints in Escherichia coli. Nat. Commun. 11, 5970 (2020).","journal-title":"Nat. Commun."},{"key":"94645_CR16","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1038\/ncomms6792","volume":"5","author":"S Suzuki","year":"2014","unstructured":"Suzuki, S., Horinouchi, T. & Furusawa, C. Prediction of antibiotic resistance by gene expression profiles. Nat. Commun. 5, 5792 (2014).","journal-title":"Nat. Commun."},{"key":"94645_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2017.12.012","volume":"172","author":"L Imamovic","year":"2018","unstructured":"Imamovic, L. et al. Drug-driven phenotypic convergence supports rational treatment strategies of chronic infections. Cell 172, 121\u2013134 (2018).","journal-title":"Cell"},{"key":"94645_CR18","doi-asserted-by":"publisher","first-page":"aad3292","DOI":"10.1126\/science.aad3292","volume":"351","author":"M Baym","year":"2016","unstructured":"Baym, M., Stone, L. K. & Kishony, R. Multidrug evolutionary strategies to reverse antibiotic resistance. Science 351, aad3292 (2016).","journal-title":"Science"},{"key":"94645_CR19","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1093\/molbev\/msx158","volume":"34","author":"C Barbosa","year":"2017","unstructured":"Barbosa, C. et al. Alternative evolutionary paths to bacterial antibiotic resistance cause distinct collateral effects. Mol. Biol. Evol. 34, 2229\u20132244 (2017).","journal-title":"Mol. Biol. Evol."},{"key":"94645_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41467-018-08098-6","volume":"10","author":"D Nichol","year":"2019","unstructured":"Nichol, D. et al. Antibiotic collateral sensitivity is contingent on the repeatability of evolution. Nat. Commun. 10, 334 (2019).","journal-title":"Nat. Commun."},{"key":"94645_CR21","unstructured":"World Health Organization. 2019. Consolidated Guidelines on Tuberculosis Treatment. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/311389\/9789241550529-eng.pdf?ua=1."},{"key":"94645_CR22","first-page":"332","volume":"133","author":"J Vashist","year":"2011","unstructured":"Vashist, J., Tiwari, V., Das, R., Kapil, A. & Rajeswari, M. R. Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii. Indian J. Med. Res. 133, 332\u2013338 (2011).","journal-title":"Indian J. Med. Res."},{"key":"94645_CR23","first-page":"20","volume":"4","author":"J Hawkey","year":"2018","unstructured":"Hawkey, J. et al. Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection. Microb. Genom. 4, 20 (2018).","journal-title":"Microb. Genom."},{"key":"94645_CR24","doi-asserted-by":"publisher","first-page":"fnz109","DOI":"10.1093\/femsle\/fnz109","volume":"336","author":"M Yang","year":"2019","unstructured":"Yang, M. et al. OxiR specifically responds to isoniazid and regulates isoniazid susceptibility in mycobacteria. FEMS Microbiol. Lett. 336, fnz109 (2019).","journal-title":"FEMS Microbiol. Lett."},{"key":"94645_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/AAC.05702-11","volume":"56","author":"KS Long","year":"2012","unstructured":"Long, K. S. & Vester, B. Resistance to linezolid caused by modifications at its binding site on the ribosome. Antimicrob. Agents Chemother. 56, 603\u2013612 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"94645_CR26","doi-asserted-by":"publisher","first-page":"e00165","DOI":"10.1128\/AAC.00165-18","volume":"62","author":"Z Zong","year":"2018","unstructured":"Zong, Z. et al. Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China. Antimicrob. Agents Chemother. 62, e00165-e218 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"94645_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-014-0292-5","author":"Y Tian","year":"2020","unstructured":"Tian, Y. et al. Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai. China. https:\/\/doi.org\/10.1186\/s12866-014-0292-5 (2020).","journal-title":"China."},{"key":"94645_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1128\/AAC.47.1.283-291.2003","volume":"47","author":"Z Feng","year":"2003","unstructured":"Feng, Z. & Barlett, R. Roles of Mycobacterium smegmatis d-alanine:d-alanine ligase and d-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor d-cycloserine. Antimicrob. Agents Chemother. 47, 283\u2013291 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"94645_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1039\/C5MB00590F","volume":"12","author":"S Suzuki","year":"2016","unstructured":"Suzuki, S., Horinouchi, T. & Furusawa, C. Phenotypic changes associated with the fitness cost in antibiotic resistant Escherichia coli strains. Mol. Biosyst. 12, 414\u2013420 (2016).","journal-title":"Mol. Biosyst."},{"key":"94645_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0966-842X(01)02168-0","volume":"9","author":"J-M Reyrat","year":"2001","unstructured":"Reyrat, J.-M. & Kahn, D. Mycobacterium smegmatis: An absurd model for tuberculosis?. Trends Microbiol. 9, 472\u2013473 (2001).","journal-title":"Trends Microbiol."},{"key":"94645_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0005883","volume":"11","author":"S Malhotra","year":"2017","unstructured":"Malhotra, S., Vedithi, S. C. & Blundell, T. L. Decoding the similarities and differences among mycobacterial species. PLoS Negl. Trop. Dis. 11, 1\u201318 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"94645_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.01619-19","volume":"63","author":"SJT Wardell","year":"2019","unstructured":"Wardell, S. J. T. et al. A large-scale whole-genome comparison shows that experimental evolution in response to antibiotics predicts changes in naturally evolved clinical Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 63, 1\u201314 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"94645_CR33","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tim.2016.03.007","volume":"24","author":"V Eldholm","year":"2016","unstructured":"Eldholm, V. & Balloux, F. Antimicrobial resistance in Mycobacterium tuberculosis: The odd one out. Trends Microbiol. 24, 637\u2013648 (2016).","journal-title":"Trends Microbiol."},{"key":"94645_CR34","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/jac\/dkv475","volume":"71","author":"M Adler","year":"2016","unstructured":"Adler, M., Anjum, M., Andersson, D. I. & Sandegren, L. Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli. J. Antimicrob. Chemother. 71, 1188\u20131198 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"94645_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bbrc.2014.04.116","volume":"448","author":"WX Xu","year":"2014","unstructured":"Xu, W. X. et al. The Wag31 protein interacts with AccA3 and coordinates cell wall lipid permeability and lipophilic drug resistance in Mycobacterium smegmatis. Biochem. Biophys. Res. Commun. 448, 255\u2013260 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"94645_CR36","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/jac\/38.6.1049","volume":"38","author":"L Amaral","year":"1996","unstructured":"Amaral, L., Kristiansen, J. E., Abebe, L. S. & Millett, W. Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: Potential use for initial therapy of freshly diagnosed tuberculosis. J. Antimicrob. Chemother. 38, 1049\u20131053 (1996).","journal-title":"J. Antimicrob. Chemother."},{"key":"94645_CR37","doi-asserted-by":"publisher","first-page":"5870","DOI":"10.1128\/AAC.00829-13","volume":"57","author":"S Musuka","year":"2013","unstructured":"Musuka, S. et al. Thioridazine pharmacokinetic-pharmacodynamic parameters \u2018wobble\u2019 during treatment of tuberculosis: A theoretical basis for shorter-duration curative monotherapy with congeners. Antimicrob. Agents Chemother. 57, 5870\u20135877 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"94645_CR38","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3390\/antibiotics6010003","volume":"6","author":"L Amaral","year":"2017","unstructured":"Amaral, L. & Viveiros, M. Thioridazine: A non-antibiotic drug highly effective, in combination with first line anti-tuberculosis drugs, against any form of antibiotic resistance of Mycobacterium tuberculosis due to its multi-mechanisms of action. Antibiotics 6, E3 (2017).","journal-title":"Antibiotics"},{"key":"94645_CR39","doi-asserted-by":"publisher","first-page":"11456","DOI":"10.1074\/jbc.M508844200","volume":"281","author":"T Yano","year":"2006","unstructured":"Yano, T., Lin-Sheng, L., Weinstein, E., Teh, J. S. & Rubin, H. Steady-state kinetics and inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis Type-II NADH-menaquinone oxidoreductase (NDH-2). J. Biol. Chem. 281, 11456\u201311463 (2006).","journal-title":"J. Biol. Chem."},{"key":"94645_CR40","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/jac\/dkl500","volume":"59","author":"L Amaral","year":"2007","unstructured":"Amaral, L., Martins, M. & Viveiros, M. Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J. Antimicrob. Chemother. 59, 1237\u20131246 (2007).","journal-title":"J. Antimicrob. Chemother."},{"key":"94645_CR41","volume-title":"Engineering and Analyzing Multicellular Systems Methods in Molecular Biology (Methods and Protocols)****, vol 1151","author":"DE Deatherage","year":"2014","unstructured":"Deatherage, D. E. & Barrick, J. E. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. In Engineering and Analyzing Multicellular Systems Methods in Molecular Biology (Methods and Protocols)****, vol 1151 (eds Sum, L. & Shou, W.) (Humana Press, 2014)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94645-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94645-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94645-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T11:43:44Z","timestamp":1670067824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94645-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["94645"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-94645-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]},"assertion":[{"value":"10 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15136"}}